| Trial ID: | L1246 |
| Source ID: | NCT01785758
|
| Associated Drug: |
Sugammadex (4 Mg/Kg)
|
| Title: |
Efficacy and Safety of Sugammadex in Renal Diseased Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic|Neuromuscular Blockade
|
| Interventions: |
DRUG: Sugammadex (4 mg/Kg)
|
| Outcome Measures: |
Primary: Time from administration of sugammadex to recovery of the train-of-four ratio (TOF) to 0.9, 2 hours | Secondary: Time from administration of sugammadex to recovery of the train-of-four ratio (TOF) to 0.7 and 0.8, 2 hours | Other: Reoccurrence of neuromuscular blockade, Patients will be monitored for evidence of reoccurrence of neuromuscular blockade for the first two hours after administration of sugammadex and clinically reevaluated after 24 hours, 24 hours
|
| Sponsor/Collaborators: |
Sponsor: Federal University of São Paulo | Collaborators: Hospital General Universitario Santa Lucía
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-10
|
| Completion Date: |
2012-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-02-07
|
| Locations: |
Hospital do Rim e Hipertensão - Fundação Oswaldo Ramos, São Paulo, SP, 04038002, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT01785758
|
